Toxicology & Pharmacology Conference to be held in Rome, Italy during March 23 - 24 2020.
Toxicology and Risk Assessment
Get link
Facebook
X
Pinterest
Email
Other Apps
The risk assessment is based on a chemical characterization of the test article, published information from the toxicological literature, and tolerable exposure limits, which may be adopted from published guidelines or derived on the basis of available toxicology data. The objective of a toxicological risk assessment is to evaluate the potential health risks associated with exposure to leachable impurities, contaminants, or other residues in a medical device or drug product. Based on the data from a chemical characterization, the risk assessment is to make a determination as to whether the release of chemicals during the use of a medical device or drug formulation may represent a toxicological risk that is unacceptable from a regulatory perspective. TRA is a research-based evaluation comprised of four activities: Hazard identification and data evaluation; Exposure assessment; Dose-response analysis; Risk characterization.
Toxinology is the specialized area of science that deals specifically with animal, plant, and microbial toxins. Toxinology has been defined as "the scientific discipline dealing with microbial , plant and animal venoms, poisons and toxins". "Toxinology includes more than just the chemistry and mode of action of a toxin. It deals also with the biology of venom- or poison-producing organism, the structure and function of the venom apparatus, as well as the use of the venom or poison, the ecological role of these compounds". Toxinology has also been defined as "the science of toxic substances produced by or accumulated in living organisms, their properties, and their biological significance for the organisms involved". For more: http://www.globalepisteme.org/Conference/toxicology-pharmacology-conference/ For abstract submission: http://www.globalepisteme.org/Conference/toxicology-pharmacology-conference/submitabstract Contact ...
Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes preclinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug For more: http://www.globalepisteme.org/Conference/toxicology-pharmacology-conference/ For abstract submission: http://www.globalepisteme.org/Conference/toxicology-pharmacology-conference/submitabstract Contact us: toxicology@globalepisteme.com
Systems Toxicology as a branch of science that aims to quantitatively understand, model, and predict the response of cells to external stimuli and expand this to model organ and body systems. Within the context of chemical exposure measurements and a causal succession of molecular events linking exposures with toxicity and eventual disease outcome, Systems Toxicology allows us to build a detailed understanding of the mechanisms by which biological systems respond to toxicants , and to use this understanding to assess the risk of chemicals, drugs and consumer products. For more: http://www.globalepisteme.org/Conference/toxicology-pharmacology-conference/ For abstract submission: http://www.globalepisteme.org/Conference/toxicology-pharmacology-conference/submitabstract Contact us: toxicology@globalepisteme.com
Comments
Post a Comment